SPINRAZA

Google image searchProduct monograph

Active ingredient

nusinersen (nusinersen sodium), 2.4 MG/ML

DIN: 02465663

Dosage form(s): SOLUTION

Route(s) of administration: INTRATHECAL

Description: SINGLE USE VIAL

Schedule: Prescription

Company: BIOGEN CANADA INC

Date: 29-AUG-2017

ATC:

• M09 — OTHER DRUGS FOR DISORDERS OF THE MUSCULOSKELETAL SYSTEM (ATC, ATC/DDD, )
• M09A — OTHER DRUGS FOR DISORDERS OF THE MUSCULOSKELETAL SYSTEM (ATC, ATC/DDD)
• M09AX — Other drugs for disorders of the musculo-skeletal system (ATC, ATC/DDD)
• M09AX07 — NUSINERSEN (ATC/DDD)

External Links for Spinraza

Search on Google

• Spinraza side effects
• Spinraza dosage
• nusinersen side effects
• nusinersen dosage